Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 2, 2013, Pages 142-148

  Gallego Escuredo, José M ^a,b   Villarroya, Joan ^a,c,d   Domingo, Pere ^c,d   Targarona, Eduard M ^d   Alegre, Marta ^d   Domingo, Joan C ^a,b   Villarroya, Francesc ^a,b   Giralt, Marta ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Red de Investigación en SIDA RIS   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adipogenesis; Inflammation; Lipodystrophy; Mitochondria; Subcutaneous adipose tissue; Visceral adipose tissue

Indexed keywords

CD68 ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV 1 ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFLAMMATION; INTRAABDOMINAL FAT; LIPID STORAGE; LIPODYSTROPHY; MALE; MARKER GENE; METABOLISM; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTOKINES; DNA, MITOCHONDRIAL; FEMALE; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

EID: 84885305303     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829bdb67     Document Type: Article

References (35)

1. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352: 48-62.
2. Wohl DA, McComsey G, Tebas P, et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis. 2006;43: 645-653.
3. Giralt M, Díaz-Delfín J, Gallego-Escuredo JM, et al. Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment. Curr Pharm Des. 2010;16: 3371-3378.
4. Caron-DebarleM, Lagathu C, Boccara F, et al. HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med. 2010;16: 218-229.
5. Domingo P, Estrada V, López-Aldeguer J, et al. Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy. AIDS Rev. 2012;14: 112-123.
6. Bastard JP, Caron M, Vidal H, et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet. 2002;359: 1026-1031.
7. Pace CS, Martin AM, Hammond EL, et al. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Antivir Ther. 2003;8: 323-331.
8. Giralt M, Domingo P, Guallar JP, et al. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Antivir Ther. 2006;11: 729-740.
9. Sevastianova K, Sutinen J, Kannisto K, et al. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab. 2008;295:E85-E91.
10. Fontdevila J, Martinez E, Rubio-Murillo JM, et al. A practical classification for the surgical filling of facial lipoatrophy. Antivir Ther. 2005;10 (suppl 3):L28.
11. Gobin SJ, Biesta P, Van den Elsen PJ. Regulation of human beta 2-microglobulin transactivation in hematopoietic cells. Blood. 2003; 101: 3058-3064.
12. He G, Andersen O, Haugaard SB, et al. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. Eur J Clin Invest. 2005;35: 583-590.
13. Bell LN, Cai L, Johnstone BH, et al. A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab. 2008;294:E336-E344.
14. Villarroya F, Domingo P, Giralt M. Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity. Trends Pharmacol Sci. 2005; 26: 88-93.
15. Kim MJ, Jardel C, Barthélémy C, et al. Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy. Antimicrob Agents Chemother. 2008; 52: 1670-1676.
16. McComsey GA, Libutti DE, O'Riordan M, et al. Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection. Antivir Ther. 2008;13: 715-722.
17. Sievers M, Walker UA, Sevastianova K, et al. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. J Infect Dis. 2009;200: 252-262.
18. Villarroya J, Giralt M, Villarroya F. Mitochondrial DNA: an up-and-coming actor in white adipose tissue pathophysiology. Obesity (Silver Spring). 2009;17: 1814-1820.
19. Gerschenson M, Kim C, Berzins B, et al. Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. J Antimicrob Chemother. 2009;63: 1244-1250.
20. Guallar JP, Gallego-Escuredo JM, Domingo JC, et al. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. AIDS. 2008;22: 575-584.
21. Jan V, Cervera P, Maachi M, et al. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir Ther. 2004;9: 555-564.
22. Johnson JA, Albu JB, Engelson ES, et al. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab. 2004;286:E261-E271.
23. Jones SP, Qazi N, Morelese J, et al. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J Acquir Immune Defic Syndr. 2005;40: 565-572.
24. Saumoy M, López-Dupla M, Veloso S, et al. The IL-6 system in HIV-1- infection and in HAART-related fat redistribution syndromes. AIDS. 2008;22: 893-896.
25. Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNFalpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab. 2003; 285:E1072-E1080.
26. Leroyer S, Vatier C, Kadiri S, et al. Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue. J Lipid Res. 2011;52: 207-220.
27. Juge-Aubry CE, Somm E, Giusti V, et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes. 2003;52: 1104-1110.
28. Sacks HS, Fain JN, Cheema P, et al. Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care. 2011;34: 730-733.
29. Avettand-Fenoel V, Kim M, Antuna B, et al. Macrophage recruitment in adipose tissue form HIV-infected patients under ART: concomitant presence of classically activated pro-inflammatory M1 and alternatively activated M2 macrophages. Antivir Ther. 2007;12(suppl 2):L13.
30. Bruun JM, Lihn AS, Pedersen SB, et al. Monocyte chemoattractant protein- 1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab. 2005;90: 2282-2289.
31. Harman-Boehm I, Blüher M, Redel H, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab. 2007;92: 2240-2247.
32. Xu H, Hotamisligil GS. Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett. 2001;506: 97-102.
33. Prins JB, Niesler CU, Winterford CM, et al. Tumor necrosis factoralpha induces apoptosis of human adipose cells. Diabetes. 1997;46: 1939-1944.
34. Lindegaard B, Hansen AB, Pilegaard H, et al. Adipose tissue expression of IL-18 and HIV-associated lipodystrophy. AIDS. 2004;18: 1956-1958.
35. Torriani M, Fitch K, Stavrou E, et al. Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. J Clin Endocrinol Metab. 2012;97:E602-E607.